Comparison of labour outcomes with and without use of test dose for labour analgesia

Comparison of labour epidural outcome with and without test dose-a randomized control study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039117

Enrollment

Registered

2022-01-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Group T : 3ml of 2% lignocaine with adrenaline will be used as test dose Control Intervention1: Group N: 3ml of saline will be used as test dose Control Intervention2: Group N: 3ml of

Eligibility

Inclusion criteria

Inclusion criteria: All consenting parturient of American society of anaesthesiologists, grade 2 having uncomplicated cephalic singleton pregnancy between age group of 18 t0 40 years and desirous of having a labour epidural

Exclusion criteria

Exclusion criteria: Patients with hypersensitivity to study drugs, bleeding disorders, decreased platelet counts, sepsis, spinal column deformities and history of spine surgery will be excluded from the study.

Design outcomes

Primary

Measure	Time frame
The primary objective of our study is to compare the incidence of numbness associated with labour epidural with and without a test dose.Timepoint: upto delivery	—

Secondary

Measure	Time frame
The secondary objectives include comparison of onset of analgesia, duration of analgesia with the first bolus dose, hemodynamics, mode of delivery and fetal outcome (assessed by umbilical vein ABG and Apgar score).Timepoint: upto delivery	—

Countries

India

Contacts

Public ContactNitu PV

Amrita Institute of medical Sciences

nituveesundeep@gmail.com09495962020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026